Oncology

All Items

• DOI: 10.12890/2025_005153

  Budd-Chiari syndrome as the presenting feature of systemic immunoglobulin light chain amyloidosis

  João Luís Miranda, Catarina Salvado, Francisca Carmo, Adriana Guedes, Albina Moreira, Tiago Guimarães Costa, Leonor Silva

• DOI: 10.12890/2025_005233

  Metachronous occurrence of acute myeloid leukaemia in a case of neuroendocrine tumour

  Abhinav Menon, Dilip Harindran Vallathol, Deepak Charles, Shagos Nair, Karthika Kundil Veetil, Ashok S. Komaranchath, Arun R. Warrier

• DOI: 10.12890/2025_005184

  Aggressively quick: a case of negative radiographic evidence progressing to a large lobulated lung mass in six months

  Nizar Alyassin, Karam Zakharia, Mubarak Yusuf, Laxminarayan Prabhakar, Medhat Ismail

• DOI: 10.12890/2025_005114

  Hemophagocytic lymphohistiocytosis secondary to dengue fever

  Simon Kashfi, Joon Yup Kim, Naomi Shohet, Shams Shakil, Manile Dastagir

• DOI: 10.12890/2025_005074

  The optimal treatment of invasive ductal and lobular carcinoma occurring at the same time needs to be established

  Supriya Peshin, Rafi Iftekher, Rabia Iqbal, Shagun Singh, Moka Nagaishwarya

• DOI: 10.12890/2024_004885

  Hepatic sinusoidal obstruction syndrome (SOS) associated with checkpoint inhibitor therapy

  Marianna Litterio, Nicole Marchetti, Francesco Carubbi, Marianna Tudini, Luciano Mutti, Claudio Ferri

• DOI: 10.12890/2024_005040

  Prognostic impact of aetiology in adult hemophagocytic lymphohistiocytosis: insights from an intensive care unit experience

  Rita Noversa de Sousa, Andreia Sá Lima, Susana Viana, Filipa Guimarães, Marta Pereira, Luís Miguel Afonso

• DOI: 10.12890/2024_005003

  Severe cutaneous toxicity in a 67-year-old patient with metastatic urothelial carcinoma undergoing therapy with enfortumab vedotin and pembrolizumab

  Benjamin Müller, Riccardo Curatolo, Hazem Juratli, Almir Husic, Josephine Nehring, Eliska Potlukova, Angela Kohler

• DOI: 10.12890/2024_004887

  Partial response to treatment with ALK inhibitor in a patient with SQSTM1-ALK fusion positive lung adenocarcinoma

  Brenda Paola Rodriguez Arroyo, Alvaro Mondragón-Cardona, Rafael Adrián Pacheco-Orozco, Andrea Tamayo, Juan Camilo Moreno, Juan Camilo Baena-Valencia

• DOI: 10.12890/2024_004981

  Can you diagnose immune thrombocytopenia in myeloma? A case of thrombocytopenia in a patient with multiple myeloma

  Cláudia Diogo, Carolina Fernandes, Sandra Cunha, Luís Luz, João Gaião Santos, Joana Raquel Monteiro